Japan · Delayed Price · Currency is JPY SUSMED,Inc. Statistics
Total Valuation
SUSMED,Inc. has a market cap or net worth of JPY 9.57 billion. The enterprise value is 5.87 billion.
| Market Cap | 9.57B |
| Enterprise Value | 5.87B |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SUSMED,Inc. has 16.81 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 16.81M |
| Shares Outstanding | 16.81M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 42.64% |
| Owned by Institutions (%) | 14.61% |
| Float | 7.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.25 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.39
| Current Ratio | 27.39 |
| Quick Ratio | 27.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -9.05% and return on invested capital (ROIC) is -126.44%.
| Return on Equity (ROE) | -9.05% |
| Return on Assets (ROA) | -4.73% |
| Return on Invested Capital (ROIC) | -126.44% |
| Return on Capital Employed (ROCE) | -8.11% |
| Weighted Average Cost of Capital (WACC) | 10.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 43 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SUSMED,Inc. has paid 3.00 million in taxes.
| Income Tax | 3.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.23% in the last 52 weeks. The beta is 1.19, so SUSMED,Inc.'s price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -29.23% |
| 50-Day Moving Average | 706.24 |
| 200-Day Moving Average | 860.57 |
| Relative Strength Index (RSI) | 36.92 |
| Average Volume (20 Days) | 106,055 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SUSMED,Inc. had revenue of JPY 497.00 million and -382.00 million in losses. Loss per share was -22.67.
| Revenue | 497.00M |
| Gross Profit | 479.00M |
| Operating Income | -330.00M |
| Pretax Income | -379.00M |
| Net Income | -382.00M |
| EBITDA | -320.00M |
| EBIT | -330.00M |
| Loss Per Share | -22.67 |
Balance Sheet
The company has 3.70 billion in cash and no debt, with a net cash position of 3.70 billion or 219.95 per share.
| Cash & Cash Equivalents | 3.70B |
| Total Debt | n/a |
| Net Cash | 3.70B |
| Net Cash Per Share | 219.95 |
| Equity (Book Value) | 4.07B |
| Book Value Per Share | 241.37 |
| Working Capital | 3.88B |
Cash Flow
In the last 12 months, operating cash flow was -474.00 million and capital expenditures -74.00 million, giving a free cash flow of -548.00 million.
| Operating Cash Flow | -474.00M |
| Capital Expenditures | -74.00M |
| Depreciation & Amortization | 10.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -548.00M |
| FCF Per Share | -32.59 |
Margins
Gross margin is 96.38%, with operating and profit margins of -66.40% and -76.86%.
| Gross Margin | 96.38% |
| Operating Margin | -66.40% |
| Pretax Margin | -76.26% |
| Profit Margin | -76.86% |
| EBITDA Margin | -64.39% |
| EBIT Margin | -66.40% |
| FCF Margin | n/a |
Dividends & Yields
SUSMED,Inc. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.33% |
| Shareholder Yield | -0.33% |
| Earnings Yield | -3.99% |
| FCF Yield | -5.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUSMED,Inc. has an Altman Z-Score of 60.21 and a Piotroski F-Score of 1.
| Altman Z-Score | 60.21 |
| Piotroski F-Score | 1 |